CYTOTEC; MISODEX

SECTION 2: Hazards identification

Appearance: White to off-white tablet

Signal word

WARNING

Hazard statements

May damage fertility or the unborn child.

Additional information

Short Term: May be harmful if swallowed. May cause mild skin irritation (based on animal data). May cause stomach irritation, diarrhea, nausea, or vomiting. Long Term: Animal studies indicate that this material may cause adverse effects on the liver and gastrointestinal system. Known Clinical Effects: Ingestion of this material may cause effects similar to those seen in clinical use including effects on gastrointestinal disturbances and abdominal pain. Drugs of this class may cause menstrual irregularities, cramps, pain, postmenopausal menstrual bleeding, miscarriage, uterine rupture, bleeding and death. Miscarriages have been seen in pregnant women taking this drug. May cause adverse effects on the developing fetus. EU Indication of danger: Toxic to reproduction: Category 1 EU Hazard Symbols: EU Risk Phrases: R60 - May impair fertility. R61 - May cause harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.